On this episode of Stock Movers:
- Boeing (BA) shares gain after BofA Global Research upgraded the planemaker to buy from neutral, with analyst Ronald Epstein writing that company’s “aircraft emerged as the favored trade tool for the Trump administration in recent trade deals.”
- Moderna (MRNA) shares rise after the drugmaker won FDA approval for its second-generation Covid vaccine for all adults over 65 and anyone over 12 who has at least one risk factor for severe disease.

On this episode of Stock Movers: - Boeing (BA) shares gain after BofA Global Research upgraded the planemaker to buy from neutral, with analyst Ronald Epstein writing that company&rsquo;s &ldquo;aircraft emerged as the favored trade tool for the Trump administration in recent trade deals.&rdquo; - Moderna (MRNA) shares rise after the drugmaker won FDA approval for its second-generation Covid vaccine for all adults over 65 and anyone over 12 who has at least one risk factor for severe disease.

Listen for five-minute conversations on today's biggest winners and losers in the stock market. Subscribe for analysis on the companies making news on Wall Street.

Listen for five-minute conversations on today's biggest winners and losers in the stock market. Subscribe for analysis on the companies making news on Wall Street.

Listen for news on today's biggest winners and losers in the stock market.

Stock Movers

Boeing Gets an Upgrade, Moderna Wins FDA Vaccine Approval

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/83dedd8e-fb4d-4e0b-8462-b2f000eca4fe/transcript

On this episode of Stock Movers:
- BAE Systems and Leonardo shares fall as much as 1.6% as Deutsche Bank cuts its ratings as part of several changes in European defense. Thales is down as much as 2.3%
- Diageo — the maker of Guinness and Johnnie Walker — is considering options for its China assets, including a sale. Advisers have been tasked with sounding out interest from local buyers and private equity houses. Shares rose more than 2% in early trading on the news, as investors kept spirits up.
- Raspberry Pi shares drop as much as 10%, slumping to a record low, after the computing company’s strong results were overshadowed by its warning over the rapid increase in the cost of DRAM memory chips.

On this episode of Stock Movers: - BAE Systems and Leonardo shares fall as much as 1.6% as Deutsche Bank cuts its ratings as part of several changes in European defense. Thales is down as much as 2.3% - Diageo&nbsp;&mdash; the maker of&nbsp;Guinness&nbsp;and&nbsp;Johnnie Walker&nbsp;&mdash;&nbsp;is considering options for its China assets, including a sale. Advisers have been tasked with sounding out interest from local buyers and private equity houses. Shares rose more than 2% in early trading on the news, as investors kept spirits up. - Raspberry Pi&nbsp;shares drop as much as 10%, slumping to a record low, after the computing company&rsquo;s strong results were overshadowed by its warning over the rapid increase in the cost of DRAM memory chips.

BAE Systems Slides, Diageo Up, Raspberry Pi Slumps

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/e6200fb3-c27c-41c2-81dc-b3d100a61be2/transcript

On this episode of Stock Movers:
- Orsted shares surged after a US judge ruled work can resume on a wind farm off the coast of Rhode Island while it challenges the government’s latest attempt to stop offshore projects from being built.
- Diageo — the maker of Guinness and Johnnie Walker — is considering options for its China assets, including a sale. Advisers have been tasked with sounding out interest from local buyers and private equity houses. Shares rose more than 2% in early trading on the news, as investors kept spirits up.
- While expectations entering 2026 are higher for European semiconductors following sharp re-rating in 2025, analysts at Jefferies expect the sector to face a “choppy ride", noting that underlying trends for most companies remain “subdued” in their estimation. In semicap, they downgrade ASM International and VAT Group to Underperform.

On this episode of Stock Movers: - Orsted&nbsp;shares surged after a US judge ruled work can resume on a wind farm off the coast of Rhode Island while it challenges the government&rsquo;s latest attempt to stop offshore projects from being built. - Diageo&nbsp;&mdash; the maker of&nbsp;Guinness&nbsp;and&nbsp;Johnnie Walker&nbsp;&mdash;&nbsp;is considering options for its China assets, including a sale. Advisers have been tasked with sounding out interest from local buyers and private equity houses. Shares rose more than 2% in early trading on the news, as investors kept spirits up. - While expectations entering 2026 are higher for European semiconductors following sharp re-rating in 2025, analysts at Jefferies expect the sector to face a &ldquo;choppy ride", noting that underlying trends for most companies remain &ldquo;subdued&rdquo; in their estimation. In semicap, they downgrade&nbsp;ASM International&nbsp;and&nbsp;VAT Group&nbsp;to Underperform.

Orsted Soars, Diageo Rises, ASM Downgraded

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/2c8c8611-5794-4864-b546-b3d10096f120/transcript

On this episode of Stock Movers:

- Eli Lilly (LLY) said Monday it expects its highly anticipated weight-loss pill to receive US regulatory approval as early as the second quarter of 2026, slightly later than it signaled earlier. Drugmakers believe weight-loss pills could expand the market for popular GLP-1 medicines, which up until earlier this year were only sold as injections. In December, Novo Nordisk won approval to sell a pill version of its blockbuster obesity shot Wegovy in the US, a crucial step in its effort to defend its market share from Lilly.

- Shake Shack (SHAK) shares slipped after the burger chain reported preliminary fourth-quarter sales below Wall Street estimates. Preliminary revenue was $400.5 million, below the $409 million average estimate of analysts surveyed by Bloomberg, with Shake Shack blaming inclement weather for keeping diners away. Shake Shack expects sales to expand by low-single digits in 2026, compared with analyst expectations for 2.4% growth, and plans to open 95 to 105 company-operated and licensed locations this year.

- Abercrombie & Fitch (ANF) shares sank after holiday sales disappointed investors, helping spark a selloff in retail stocks. The company now expects fourth-quarter sales growth of around 5%, the mid-point of its prior range, and didn’t raise its outlook. Shares of Abercrombie plummeted 18% on Monday, while American Eagle and Urban Outfitters also sank after their holiday results underwhelmed Wall Street.

On this episode of Stock Movers: - Eli Lilly (LLY) said Monday it expects its highly anticipated weight-loss pill to receive US regulatory approval as early as the second quarter of 2026, slightly later than it signaled earlier. Drugmakers believe weight-loss pills could expand the market for popular GLP-1 medicines, which up until earlier this year were only sold as injections. In December, Novo Nordisk won approval to sell a pill version of its blockbuster obesity shot Wegovy in the US, a crucial step in its effort to defend its market share from Lilly. - Shake Shack (SHAK) shares slipped after the burger chain reported preliminary fourth-quarter sales below Wall Street estimates. Preliminary revenue was $400.5 million, below the $409 million average estimate of analysts surveyed by Bloomberg, with Shake Shack blaming inclement weather for keeping diners away. Shake Shack expects sales to expand by low-single digits in 2026, compared with analyst expectations for 2.4% growth, and plans to open 95 to 105 company-operated and licensed locations this year. - Abercrombie &amp; Fitch (ANF) shares sank after holiday sales disappointed investors, helping spark a selloff in retail stocks. The company now expects fourth-quarter sales growth of around 5%, the mid-point of its prior range, and didn&rsquo;t raise its outlook. Shares of Abercrombie plummeted 18% on Monday, while American Eagle and Urban Outfitters also sank after their holiday results underwhelmed Wall Street.

Eli Lilly Rises, Shake Shack Declines, Abercrombie & Fitch Sinks

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/2f78ae5a-7b55-4656-a492-b3d0016c4ad1/transcript

Boeing Gets an Upgrade, Moderna Wins FDA Vaccine Approval

In 1 playlist(s)

Stock Movers

Social links

Follow podcast

Recent clips